Renhe PharmacyLtd Yönetim

Yönetim kriter kontrolleri 3/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Wujun Huang

İcra Kurulu Başkanı

CN¥679.3k

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	no data
CEO sahipliği	0.002%
Yönetim ortalama görev süresi	11.9yrs
Yönetim Kurulu ortalama görev süresi	6.5yrs

Son yönetim güncellemeleri

Recent updates

CEO

Wujun Huang (56 yo)

no data

Görev süresi

CN¥679,300

Tazminat

Mr. Huang Wujun serves as Employee-Representative Member of the Supervisory Board at Renhe Pharmacy Co., Ltd. since December 11, 2015. Mr. Huang worked at Jiangxi Pharmaceutical Co., Ltd.as Deputy Directo...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Wujun Huang	GM & Director	no data	CN¥679.30k	0.0017% CN¥ 132.6k
Qiu Lin Peng	CFO & Non-Independent Director	14.4yrs	CN¥666.70k	Veri yok
Zi Qiang Zhang	Deputy GM & Employee Director	11.9yrs	CN¥1.17m	Veri yok
Feng Jiang	Secretary of the Board & Non-Independent Director	no data	CN¥365.10k	Veri yok
Guofeng Chen	Deputy General Manager	1.3yrs	CN¥155.20k	Veri yok

11.9yrs

Ortalama Görev Süresi

53yo

Ortalama Yaş

Deneyimli Yönetim: 000650 'un yönetim ekibi deneyimli ve deneyimlidir ( 11.9 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Wujun Huang	GM & Director	no data	CN¥679.30k	0.0017% CN¥ 132.6k
Qiu Lin Peng	CFO & Non-Independent Director	14.4yrs	CN¥666.70k	Veri yok
Zi Qiang Zhang	Deputy GM & Employee Director	11.9yrs	CN¥1.17m	Veri yok
Feng Jiang	Secretary of the Board & Non-Independent Director	2.7yrs	CN¥365.10k	Veri yok
Shutian Tu	Independent Director	2.7yrs	CN¥81.00k	Veri yok
Zhenglian Xiao	Vice Chairman of the Board of Directors	17.9yrs	CN¥1.43m	Veri yok
Dong Ling Ji	Non-Employee Supervisor	9.9yrs	Veri yok	Veri yok
Xiao Yang	Chairman	6.5yrs	CN¥913.20k	6.6% CN¥ 520.9m
Yuesheng Wang	Independent Director	5.7yrs	CN¥81.00k	Veri yok
Yaxiong Guo	Independent Director	5.7yrs	CN¥81.00k	Veri yok
Zhihua Kang	Non-Employee Supervisor	8.2yrs	Veri yok	Veri yok
Wanqiu Luo	Chairman of Supervisory Board	2.7yrs	Veri yok	Veri yok

6.5yrs

Ortalama Görev Süresi

54.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 000650 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 6.5 yıldır).

Renhe PharmacyLtd Yönetim

Yönetim kriter kontrolleri 3/4

Anahtar bilgiler

Son yönetim güncellemeleri

Renhe Pharmacy Co., Ltd., Annual General Meeting, May 24, 2024

Renhe Pharmacy Co., Ltd., Annual General Meeting, May 30, 2023

Recent updates

Third quarter 2024 earnings released: EPS: CN¥0.056 (vs CN¥0.13 in 3Q 2023)

Investor sentiment improves as stock rises 21%

Renhe Pharmacy Co.,Ltd to Report Q3, 2024 Results on Oct 29, 2024

Second quarter 2024 earnings released: EPS: CN¥0.11 (vs CN¥0.12 in 2Q 2023)

Renhe Pharmacy Co.,Ltd to Report First Half, 2024 Results on Aug 28, 2024

Renhe Pharmacy Co., Ltd., Annual General Meeting, May 24, 2024

Renhe Pharmacy Co., Ltd. Proposes Final Cash Dividend for the Year 2023

Full year 2023 earnings released: EPS: CN¥0.41 (vs CN¥0.41 in FY 2022)

Renhe Pharmacy Co., Ltd. to Report Q1, 2024 Results on Apr 30, 2024

Investor sentiment improves as stock rises 15%

Renhe Pharmacy Co., Ltd. to Report Fiscal Year 2023 Results on Apr 26, 2024

Renhe Pharmacy Co., Ltd. (SZSE:000650) announces an Equity Buyback for CNY 150 million worth of its shares.

Investor sentiment improves as stock rises 15%

Renhe Pharmacy Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on 08 June 2023

Renhe Pharmacy Co., Ltd., Annual General Meeting, May 30, 2023

Investor sentiment improved over the past week

Third quarter 2022 earnings released: EPS: CN¥0.11 (vs CN¥0.14 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.10 (vs CN¥0.13 in 2Q 2021)

Renhe Pharmacy Co., Ltd. Announces Final Dividend on A Shares for the Year 2021, Payable on May 27, 2022

Renhe Pharmacy Co., Ltd. Approves Final Cash Dividend for 2021

Renhe Pharmacy Co., Ltd. Proposes Final Cash Dividend for the Year 2021

First quarter 2022 earnings released: EPS: CN¥0.11 (vs CN¥0.11 in 1Q 2021)

Third quarter 2021 earnings released: EPS CN¥0.14 (vs CN¥0.10 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.13 (vs CN¥0.12 in 2Q 2020)

Renhe Pharmacy Co., Ltd Announces 2020 Final Distribution for A shares, Payable on 31 May 2021

Investor sentiment improved over the past week

Renhe Pharmacy Co., Ltd. Approves Cash Dividend for the Year 2020

Investor sentiment improved over the past week

Full year 2020 earnings released: EPS CN¥0.45 (vs CN¥0.43 in FY 2019)

Renhe Pharmacy Co., Ltd. to Report Fiscal Year 2020 Results on Apr 23, 2021

New 90-day low: CN¥5.72

New 90-day low: CN¥6.00

New 90-day high: CN¥7.19

Third quarter earnings released

New 90-day low: CN¥6.13

First half earnings released

Renhe Pharmacy Co., Ltd to Report First Half, 2020 Results on Aug 28, 2020

CEO

Görev süresi

Tazminat

Liderlik Ekibi

Ortalama Görev Süresi

Ortalama Yaş

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş